Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Eczema (Atopic Dermatitis) Clinical Trials

A listing of Eczema (Atopic Dermatitis) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (174) clinical trials

A study to evaluate the safety and effectiveness of a new, unmarketed, version of Tacrolimus Ointment 0.1% compared to Protopic 0.1% or a placebo ointment in subjects with eczema (atopic dermatitis).

Phase N/A

Study to evaluate the safety and effectiveness of a generic Pimecrolimus Cream 1%, to Elidel Cream 1% and to placebo cream, when used in subjects with eczema (atopic dermatitis).

Phase N/A

Do you or your child suffer from Atopic Dermatitis or Eczema?

Phase

Atopic dermatitis (AD), which is also known as eczema, is a common chronic, relapsing skin condition associated with intense skin itching and rash, which can impact most aspects of everyday life. The exact cause of the disease is not fully known, but it involves an imbalance of the immune system ...

Phase N/A

If you've had trouble treating your eczema or atopic dermatitis, you may be eligible for a clinical research study of an investigational medication.

Phase N/A

Atopic dermatitis (AD) is a common inflammatory skin disorder that adversely affects most aspects of everyday life in majority of patients. It has a prevalence of up to 3-4% of adults and up to 25% among children. AD has a complex pathogenesis, characterized by: 1) immune activation with increased numbers ...

Phase N/A

The OXFORAD™ Study for Atopic Dermatitis is examining an investigational drug to see how safe and effective it is when given to people like you who have eczema.

Phase N/A

A research study is evaluating an investigational medication for moderate to severe atopic dermatitis, also known as eczema.

Phase N/A

A Randomized, Double-Blind, Placebo-Controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

Phase

Now enrolling ages 18 and older for moderate to severe atopic dermatitis.

Phase N/A